Suvretta Capital Management »

Protagonist Therapeutics shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.1M 31k 34.65
2024-03-31 $882k 31k 28.93
2023-09-30 $1.8M 108k 16.68
2023-06-30 $2.2M 81k 27.62

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Benitec Biopharma Com New (BNTC)
Meta Platforms Cl A (META)
Legend Biotech Corp Sponsored Ads (LEGN)
89bio (ETNB)
Immatics SHS (IMTX)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
NVIDIA Corporation (NVDA)
Eyepoint Pharmaceuticals Com New (EYPT)
Biohaven (BHVN)
Mineralys Therapeutics (MLYS)
Home Depot (HD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Suvretta Capital Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
BVF
Johnson & Johnson
Wellington Management Company
UBS Group
Deep Track Capital
Woodline Partners
Geode Capital Management
Driehaus Capital Management
Henderson Group
Marshall Wace

View all funds holding Protagonist Therapeutics